These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
461 related items for PubMed ID: 17571588
1. [Breakthrough pulmonary mucormycosis during voriconazole treatment after reduced-intensity cord blood transplantation for a patient with acute myeloid leukemia]. Shindo M, Sato K, Jimbo J, Hosoki T, Ikuta K, Sano A, Nishimura K, Torimoto Y, Kohgo Y. Rinsho Ketsueki; 2007 May; 48(5):412-7. PubMed ID: 17571588 [Abstract] [Full Text] [Related]
2. Disseminated mucormycosis associated with invasive pulmonary aspergillosis in a patient treated for post-transplant high-grade non-Hodgkin's lymphoma. Blin N, Morineau N, Gaillard F, Morin O, Milpied N, Harousseau JL, Moreau P. Leuk Lymphoma; 2004 Oct; 45(10):2161-3. PubMed ID: 15370266 [Abstract] [Full Text] [Related]
4. Breakthrough pulmonary Aspergillus fumigatus infection with multiple triazole resistance in a Spanish patient with chronic myeloid leukemia. Mellado E, De La Camara R, Buendía B, Rodriguez-Tudela JL, Cuenca-Estrella M. Rev Iberoam Micol; 2013 Jan 03; 30(1):64-8. PubMed ID: 22986228 [Abstract] [Full Text] [Related]
5. An update on the use of antifungal agents. Martinez R. J Bras Pneumol; 2006 Jan 03; 32(5):449-60. PubMed ID: 17268750 [Abstract] [Full Text] [Related]
6. A case of pulmonary aspergillosis with lack of response to caspofungin. Rüchel R, Perske C, Glass B, Bäsecke J. Rev Iberoam Micol; 2006 Jun 03; 23(2):94-6. PubMed ID: 16854185 [Abstract] [Full Text] [Related]
7. Clinical outcomes of lung-transplant recipients treated by voriconazole and caspofungin combination in aspergillosis. Thomas A, Korb V, Guillemain R, Caruba T, Boussaud V, Billaud E, Prognon P, Begué D, Sabatier B. J Clin Pharm Ther; 2010 Feb 03; 35(1):49-53. PubMed ID: 20175811 [Abstract] [Full Text] [Related]
8. Successful treatment of concomitant pulmonary zygomycosis and aspergillosis with a combination of amphotericin B lipid complex, caspofungin, and voriconazole in a patient on immunosuppression for chronic graft-versus-host disease. Verma A, Williams S, Trifilio S, Zembower T, Mehta J. Bone Marrow Transplant; 2004 May 03; 33(10):1065-6. PubMed ID: 15048146 [No Abstract] [Full Text] [Related]
9. Triple antifungal therapy for severe systemic candidiasis allowed performance of allogeneic stem cell transplantation. Gahn B, Schub N, Repp R, Gramatzki M. Eur J Med Res; 2007 Aug 16; 12(8):337-40. PubMed ID: 17933709 [Abstract] [Full Text] [Related]
10. Successful Treatment of Pulmonary Mucormycosis Caused by Cunninghamella bertholletiae with High-Dose Liposomal Amphotericin B (10 mg/kg/day) Followed by a Lobectomy in Cord Blood Transplant Recipients. Ota H, Yamamoto H, Kimura M, Araoka H, Fujii T, Umeyama T, Ohno H, Miyazaki Y, Kaji D, Taya Y, Nishida A, Ishiwata K, Tsuji M, Takagi S, Asano-Mori Y, Yamamoto G, Uchida N, Izutsu K, Masuoka K, Wake A, Yoneyama A, Makino S, Taniguchi S. Mycopathologia; 2017 Oct 16; 182(9-10):847-853. PubMed ID: 28577122 [Abstract] [Full Text] [Related]
11. Disseminated invasive aspergillosis in a patient with acute leukaemia. Gottfredsson M, Steingrímsdóttir H. Acta Biomed; 2006 Oct 16; 77 Suppl 2():10-3. PubMed ID: 16918060 [Abstract] [Full Text] [Related]
12. Successful treatment of breakthrough Trichosporon asahii fungemia with voriconazole in a patient with acute myeloid leukemia. Asada N, Uryu H, Koseki M, Takeuchi M, Komatsu M, Matsue K. Clin Infect Dis; 2006 Aug 15; 43(4):e39-41. PubMed ID: 16838224 [Abstract] [Full Text] [Related]
13. Invasive pulmonary aspergillosis with hematological malignancy caused by Aspergillus terreus and in vitro susceptibility of A. terreus isolate to micafungin. Tokimatsu I, Kushima H, Iwata A, Hashinaga K, Umeki K, Ohama M, Kohno K, Ishii H, Kishi K, Ogata M, Hiramatsu K, Saikawa T, Kadota J. Intern Med; 2007 Aug 15; 46(11):775-9. PubMed ID: 17541234 [Abstract] [Full Text] [Related]
14. [Pulmonary mucormycosis in a patient with kidney transplant and uncontrolled haemoptysis]. Navarro Vergara DI, Barragán Pola G, Bonifaz A, Núñez Pérez-Redondo C, Choreño García O, Cicero Sabido R. Rev Iberoam Micol; 2017 Aug 15; 34(4):233-236. PubMed ID: 28757006 [Abstract] [Full Text] [Related]
15. Successful management of cerebral and pulmonary mucormycosis with liposomal amphotericin B in a 28-year-old woman with acute lymphoblastic leukemia. Salonen JH. Acta Biomed; 2006 Aug 15; 77 Suppl 2():28-31. PubMed ID: 16918065 [Abstract] [Full Text] [Related]
16. Breakthrough zygomycosis during voriconazole treatment for invasive aspergillosis. Kobayashi K, Kami M, Murashige N, Kishi Y, Fujisaki G, Mitamura T. Haematologica; 2004 Nov 15; 89(11):ECR42. PubMed ID: 15533847 [No Abstract] [Full Text] [Related]
17. Mucormycoses in patients with hematologic malignancies: an emerging fungal infection. Bethge WA, Schmalzing M, Stuhler G, Schumacher U, Kröber SM, Horger M, Einsele H, Kanz L, Hebart H. Haematologica; 2005 Nov 15; 90 Suppl():ECR22. PubMed ID: 16266913 [Abstract] [Full Text] [Related]
19. Breakthrough disseminated Aspergillus ustus infection in allogeneic hematopoietic stem cell transplant recipients receiving voriconazole or caspofungin prophylaxis. Pavie J, Lacroix C, Hermoso DG, Robin M, Ferry C, Bergeron A, Feuilhade M, Dromer F, Gluckman E, Molina JM, Ribaud P. J Clin Microbiol; 2005 Sep 15; 43(9):4902-4. PubMed ID: 16145172 [Abstract] [Full Text] [Related]
20. Efficacy of voriconazole plus amphotericin B or micafungin in a guinea-pig model of invasive pulmonary aspergillosis. Chandrasekar PH, Cutright JL, Manavathu EK. Clin Microbiol Infect; 2004 Oct 15; 10(10):925-8. PubMed ID: 15373889 [Abstract] [Full Text] [Related] Page: [Next] [New Search]